Source comparison
Comparison Table: BPC-157 Response Timeline by Tissue Type
Gastrointestinal (ulcers, IBD) VEGF-driven mucosal angiogenesis + reduced inflammatory cytokine expression 50–70% reduction in pain, bleeding, or inflammation symptoms 4–6 weeks for complete mucosal closure Fastest responder due to high baseline vascularity. T
This comparison does not assign a generated winner or score.
- Gastrointestinal (ulcers, IBD)
- VEGF-driven mucosal angiogenesis + reduced inflammatory cytokine expression
- 50–70% reduction in pain, bleeding, or inflammation symptoms
- 4–6 weeks for complete mucosal closure
- Fastest responder due to high baseline vascularity. Two-week results most predictable here
- Tendon/Ligament Injuries
- Fibroblast activation + Type III collagen deposition begins
- 20–40% pain reduction during movement; stiffness improvement
- 6–10 weeks for structural tensile strength
- Hypovascular tissue delays visible improvement. Two weeks shows inflammation decline, not functional repair
- Muscle Strains
- Satellite cell activation + capillary proliferation at injury site
- Reduced soreness, improved contraction strength by 15–25%
- 4–6 weeks for full fiber remodeling
- Mid-range responder. Adequate blood supply accelerates early repair but full recovery requires remodeling phase
- Peripheral Nerve Damage
- Neurotrophic factor upregulation + myelin sheath regeneration initiation
- Subtle improvement in sensation or motor control (10–20% functional gain)
- 8–16 weeks for nerve conduction recovery
- Slowest tissue type. Two-week improvements are minimal, but early markers predict long-term outcomes